Bimatoprost ophthalmic solution in facial vitiligo.

BACKGROUND

Vitiligo is one of the commonest pigmentary disorders characterized by destruction of melanocytes.

AIM

To evaluate the efficacy of topical bimatoprost ophthalmic solution in stable facial vitiligo.

MATERIAL AND METHODS

Eight cases of stable facial vitiligo were treated with bimatoprost 0.03% ophthalmic solution once daily for 12 weeks. Photographic records were taken at 2 weeks follow-up along with dermoscopic (Polarized, 10×) evaluation.

RESULTS

Four cases had excellent repigmentation, two cases had partial repigmentation and two cases had poor response.

CONCLUSION

Bimatoprost seems to be promising in treating stable vitiligo but large-scale studies are required.